Pfizer has grown revenue −7.0% a year over three years and 8.5% a year over five, with earnings per share compounding at −41%. Revenue growth, 3-year annual rate: −7.0% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +8.5%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −41%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 19, FY2007 to FY2025, as filed.

PFEPfizer

HealthcareUSD

$28.32

$22.4452 weeks$28.57

Is it growing?

Is PFE growing?

Pfizer has grown revenue −7.0% a year over three years and 8.5% a year over five, with earnings per share compounding at −41%.

−7.0%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +8.5%
Revenue growth, 5-year rate · −7.0% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −41%
Earnings per share, 3-year rate · revenue −7.0% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed